MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors | Experimental Hematology & Oncology | Full Text
MET Exon 14 Skipping Alterations in NSCLC: Current Understanding and Therapeutic Advances - touchONCOLOGY
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
When the MET receptor kicks in to resist targeted therapies | Oncogene
Targeting un-MET needs in advanced non-small cell lung cancer - ScienceDirect
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
Drug resistance of non-small-cell lung cancer (NSCLC) against EGFR... | Download Scientific Diagram
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews
MET and TP 53: How They Relate to ALK Lung Cancer — ALK POSITIVE
Cancers | Free Full-Text | MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
new-molecular-drivers-in-nsclc-the-role-of-met
The METeoric rise of MET in lung cancer - Friedlaender - 2020 - Cancer - Wiley Online Library
EMT, MET amplification, and IGF-1R confer resistance to EGFR TKIs.... | Download Scientific Diagram
Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lung cancer - ESMO Open
MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib - Nishiyama - 2020 - Cancer Science - Wiley Online Library
MET and TP 53: How They Relate to ALK Lung Cancer — ALK POSITIVE
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | SpringerLink
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
EGFR pathway in NSCLC. Mutations, amplification or overexpression of... | Download Scientific Diagram
Frontiers | Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer
Cancers | Free Full-Text | MET Amplification in Non-Small Cell Lung Cancer ( NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting
Advances in molecular‐based personalized non‐small‐cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance - Jotte - 2015 - Cancer Medicine - Wiley Online Library
FISH analysis of de novo MET amplification in advanced NSCLC and... | Download Scientific Diagram
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
